The product information (Summary of Product Characteristics (SmPC) and Package Leaflet (PL)) for both Gardasil and Gardasil 9 is available via the HPRA website or directly through the website of the European Medicines Agency at the links below:
The SmPC and PL are issued when a medicine is first licensed for use and are reviewed and updated as necessary throughout the lifetime of a medicine. The SmPC is mainly intended for use by healthcare professionals and includes detailed information on the use, dosing recommendations, precautions for use and the known side-effects of the medicine concerned. The package leaflet (PL), primarily intended for the patient/consumer, reflects the more comprehensive information described in the SmPC, but is required to be presented in an abbreviated and easy-to-read format for patients.
Parents/carers and other members of the public can find further information about the HPV Schools Immunisation Programme on the HSE website.